The professor of clinical neurology at University of Miami and MT2020+ chair, and president of Medtronic's Neurovascular Business discussed the effort to improve global accessibility of mechanical thrombectomy.
“While MT2020 has been very fortunate to have a roadmap that has been rapidly implemented in many regions, the resources that are really needed by these regional committees are lacking in several places. A program like IMMEDIATE could totally fortify these efforts and get the access ‘ball’ rolling a little faster.”
In mid-March 2021, Medtronic announced that it was partnering with the Society of Vascular and Interventional Neurology (SVIN) to aid in the expansion of the Mechanical Thrombectomy 2020+ (MT2020+) initiative, via collaboration with its own program, IMMEDIATE. Together, Medtronic announced, it and MT2020+ seek to overcome the barriers to treatment and improve stroke systems of care to enhance lives worldwide.
In order to find out more about the pairing of these 2 large entities and the overall mission and goals, NeurologyLive spoke with Dan Volz, president, Neurovascular Business, Medtronic, and Dileep Yavagal, MD, MT2020+ chair, and professor of clinical neurology, University of Miami, about it. The pair shared their insight into their expectations for the partnership and how it may ultimately improve the global care of patients with stroke.
Specifically, Volz shared his insight from Medtronic’s time developing devices and the like for neurovascular conditions and what the company hopes to bring to SVIN. Yavagal, on the other hand, pointed out some of the obstacles to accessing mechanical thrombectomy and highlighted the stakeholders in the stroke pathway of care.